Seer to Participate in the Canaccord Genuity 44th Annual Growth Conference
Seer, a pioneering life sciences company focused on proteomics, has announced its participation in the Canaccord Genuity 44th Annual Growth Conference in Boston, MA. The company's management team is set to engage in a fireside chat on Wednesday, August 14th at 3:00 p.m. Eastern Time.
Investors and interested parties can access a live webcast of the session through the Investor section of Seer's website at investor.seer.bio. For those unable to attend in real-time, an archived replay will be made available on the company's website following the conference, ensuring widespread access to this important corporate update.
Seer, un'azienda pionieristica nel settore delle scienze della vita, focalizzata su proteomica, ha annunciato la sua partecipazione alla 44ª Conferenza Annuale sulla Crescita di Canaccord Genuity a Boston, MA. Il team di gestione dell'azienda parteciperà a un fireside chat mercoledì 14 agosto alle 15:00, ora orientale.
Gli investitori e le persone interessate possono accedere a un webcast live della sessione attraverso la sezione Investitori del sito web di Seer su investor.seer.bio. Per coloro che non possono partecipare in tempo reale, sarà disponibile una replica archiviata sul sito dell'azienda dopo la conferenza, garantendo un ampio accesso a questo importante aggiornamento aziendale.
Seer, una empresa pionera en ciencias de la vida centrada en proteómica, ha anunciado su participación en la 44ª Conferencia Anual de Crecimiento de Canaccord Genuity en Boston, MA. El equipo de gestión de la empresa participará en una charla informal el miércoles 14 de agosto a las 3:00 p.m., hora del Este.
Los inversores y las partes interesadas pueden acceder a un webcast en vivo de la sesión a través de la sección de Inversores del sitio web de Seer en investor.seer.bio. Para aquellos que no puedan asistir en tiempo real, se pondrá a disposición una retransmisión archivada en el sitio web de la empresa tras la conferencia, asegurando un amplio acceso a esta importante actualización corporativa.
시어(Seer)는 단백질 체계학(proteomics)에 중점을 둔 선도적인 생명 과학 회사로, 캐너코드 제뉴이티 제44회 연례 성장 컨퍼런스에 참여한다고 발표했습니다. 회사 경영진은 8월 14일 수요일 오후 3시(동부 표준시)에 파이어사이드 채팅에 참여할 예정입니다.
투자자 및 관계자는 investor.seer.bio의 투자자 섹션을 통해 세션의 실시간 웹 캐스트에 접근할 수 있습니다. 실시간 참석이 불가능한 분들을 위해, 컨퍼런스 이후 회사 웹사이트에 아카이브 재생이 제공되어 이 중요한 기업 업데이트를 폭넓게 접근할 수 있도록 할 것입니다.
Seer, une entreprise innovante dans le domaine des sciences de la vie axée sur la protéomique, a annoncé sa participation à la 44e Conférence Annuelle sur la Croissance de Canaccord Genuity à Boston, MA. L'équipe de direction de l'entreprise participera à un dialogue informel le mercredi 14 août à 15h00, heure de l'Est.
Les investisseurs et les parties intéressées peuvent accéder à un webinaire en direct de la session via la section Investisseurs du site web de Seer à investor.seer.bio. Pour ceux qui ne peuvent pas assister en temps réel, une rediffusion archivée sera mise à disposition sur le site de l'entreprise après la conférence, garantissant un accès large à cette importante mise à jour d'entreprise.
Seer, ein wegweisendes Unternehmen im Bereich der Lebenswissenschaften mit Schwerpunkt auf Proteomik, hat seine Teilnahme an der 44. jährlichen Wachstums-Konferenz von Canaccord Genuity in Boston, MA, bekannt gegeben. Das Management-Team des Unternehmens wird am Mittwoch, den 14. August um 15:00 Uhr Eastern Time an einem Fireside Chat teilnehmen.
Investoren und interessierte Parteien können über den Investor-Bereich der Website von Seer auf einen Live-Webcast der Sitzung zugreifen unter investor.seer.bio. Für diejenigen, die nicht in Echtzeit teilnehmen können, wird nach der Konferenz eine archivierte Wiederholung auf der Website des Unternehmens verfügbar sein, sodass dieser wichtige Unternehmens-Update einem breiten Publikum zugänglich gemacht wird.
- None.
- None.
REDWOOD CITY, Calif., Aug. 09, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that the company will be participating in the upcoming Canaccord Genuity 44th Annual Growth Conference in Boston, MA.
Seer’s management is scheduled to participate in a fireside chat on Wednesday, August 14th at 3:00 p.m. Eastern Time / 12:00 p.m. Pacific Time. A live webcast of the session will be available on the Investor section of Seer’s website at investor.seer.bio. An archived replay will be available on the company’s website following the conference.
About Seer
Seer is a life sciences company developing transformative products that open a new gateway to the proteome. Seer’s Proteograph Product Suite is an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation and software to perform deep, unbiased proteomic analysis at scale in a matter of hours. Seer designed the Proteograph workflow to be efficient and easy to use, leveraging widely adopted laboratory instrumentation to provide a decentralized solution that can be incorporated by nearly any lab. Seer’s Proteograph Product Suite is for research use only and is not intended for diagnostic procedures. For more information, please visit www.seer.bio.
Investor Contact:
Carrie Mendivil
investor@seer.bio
Media Inquiries:
Patrick Schmidt
pr@seer.bio
FAQ
When is Seer participating in the Canaccord Genuity 44th Annual Growth Conference?
How can investors access Seer's presentation at the Canaccord Genuity conference?
What is the focus of Seer's business as mentioned in the press release?
Where is the Canaccord Genuity 44th Annual Growth Conference being held?
